DXR - Daxor Corporation News

Sectors

DXR

Daxor Corporation

10.51

1 x 10.16

1 x 10.80

bid

ask

0.00

0.00%

09:32 AM

timesize

Ytd	-28.75%
1y	14.49%

10.18

day range

11.14

8.56

52 week range

14.76

Open	10.24	Prev Close	10.51	Low	10.18	High	11.14	Mkt Cap	52.96M
Vol	6.00	Avg Vol	4.61K	EPS	0.38	P/E	27.49	Forward P/E	N/A
Beta	0.26	Short Ratio	0.60	Inst. Own	1.94%	Dividend	N/A	Div Yield	N/A
Ex Div Date	01-05	Earning	03-06	50-d Avg	10.34	200-d Avg	11.72	1yr Est	23.38

DXR News

globenewswire.com

Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conf

Daxor to Showcase How BVA Provides the Objective Plasma and Red Blood Cell Data Needed to Target Dys

globenewswire.com

Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor

New Technology Expands Daxor's Diagnostic Capabilities to Enable Continuous, Remote Tracking of Bloo

globenewswire.com

Daxor Leverages MedAxiom CV Transforum Spring'26 to Accelerate Commercial Adoption of Blood Volume A

Oak Ridge, TN, April 28, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader

globenewswire.com

Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center

Oak Ridge, TN, April 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader

globenewswire.com

Daxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in

OAK RIDGE, TN, March 26, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader

globenewswire.com

Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting

Oak Ridge, TN, March 17, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader

seekingalpha.com

Daxor Corporation (DXR) Presents at IAccess Alpha Virtual Best Ideas Spring Investment Conference 20

globenewswire.com

Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress

Advancing Precision Fluid Management in the ICU to Reduce Mortality and Hospital Length of Stay Oak

globenewswire.com

Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conferenc

Oak Ridge, TN, March 09, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader

globenewswire.com

Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises

Strategic Realignment to Clinical Growth Supported by FDA 510(k) Clearance for Next-Generation Blood

defenseworld.net

Daxor (NASDAQ:DXR) vs. Addus HomeCare (NASDAQ:ADUS) Financial Survey

Addus HomeCare (NASDAQ: ADUS - Get Free Report) and Daxor (NASDAQ: DXR - Get Free Report) are both s

globenewswire.com

Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee

Expansion Leverages Daxor's ezBVA Lab to Deliver 98% Accurate Diagnostics with Zero Capital Investme

defenseworld.net

RadNet (NASDAQ:RDNT) & Daxor (NASDAQ:DXR) Head to Head Analysis

Daxor (NASDAQ: DXR - Get Free Report) and RadNet (NASDAQ: RDNT - Get Free Report) are both medical c

globenewswire.com

Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffir

Oak Ridge, TN, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader

defenseworld.net

Contrasting Daxor (NASDAQ:DXR) and Quest Diagnostics (NYSE:DGX)

Daxor (NASDAQ: DXR - Get Free Report) and Quest Diagnostics (NYSE: DGX - Get Free Report) are both m

globenewswire.com

Daxor Corporation Announces $9 Million Registered Direct Offering

OAK RIDGE, TN, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NasdaqCM: DXR) (“Daxor” or the “

defenseworld.net

Quest Diagnostics (NYSE:DGX) & Daxor (NASDAQ:DXR) Head-To-Head Review

Quest Diagnostics (NYSE: DGX - Get Free Report) and Daxor (NASDAQ: DXR - Get Free Report) are both m

defenseworld.net

Analyzing Daxor (NASDAQ:DXR) and Elanco Animal Health (NYSE:ELAN)

Elanco Animal Health (NYSE: ELAN - Get Free Report) and Daxor (NASDAQ: DXR - Get Free Report) are bo

defenseworld.net

Daxor (NASDAQ:DXR) Trading Down 1.4% – Here’s Why

Daxor Corporation (NASDAQ: DXR - Get Free Report)'s stock price fell 1.4% on Thursday. The stock tra

globenewswire.com

Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer

Continued Integration of ezBVA Lab Service and On-Site Analyzer Deployment Signals Accelerating Mark